Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a population-based cohort of adults with schizophrenia in Ontario, Canada

Psychiatry Research

Volumn 196, Issue 1, 2012, Pages 32-37

  Austin, Peter C ^a   Newman, Alice ^a   Kurdyak, Paul A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Administrative data; Aggregated Diagnosis Groups; Charlson comorbidity index; Comorbidity; Elixhauser comorbidities; Health services research; Schizophrenia

Indexed keywords

ACCURACY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALIBRATION; CANADA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; FEMALE; HUMAN; JOHN HOPKINS AGGREGATED DIAGNOSIS GROUP; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MORTALITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CANADA; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ONTARIO; PREDICTIVE VALUE OF TESTS; SCHIZOPHRENIA;

EID: 84860639205     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.09.023     Document Type: Article

References (29)

1. Austin P.C., van Walraven C. The Mortality Risk Score and the ADG Score: two points-based scoring systems for the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Medical Care 2011, 49(10):940-947.
2. Austin P.C., van Walraven C., Wodchis W.P., Newman A., Anderson G.M. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Medical Care 2011, 49(10):932-939.
3. Austin, P.C., Shah, B.R., Newman, A., Anderson, G.M., in press. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a population-based cohort of patients with diabetes in Ontario, Canada. Diabetic Medicine, doi:. doi:10.1111/j.1464-5491.2011.03568.x.
4. Basu A., Meltzer H.Y. Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era. Schizophrenia Research 2006, 86:99-109.
5. Berlowitz D.R., Hoenig G., Cowper D.C., Duncan P.W., Vogel W.B. Impact of comorbidities on stroke rehabilitation outcomes: does the method matter?. Archives of Physical Medicine and Rehabilitation 2008, 89:1903-1906.
6. Brown S., Kim M., Mitchell C., Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. The British Journal of Psychiatry 2010, 196:116-121.
7. Carney C.P., Jones L., Woolson R.F. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. Journal of General Internal Medicine 2006, 21(11):1133-1137.
8. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and Validation. Journal of Chronic Disease 1987, 40:373-383.
9. Copeland L.A., Zeber J.E., Wang C.P., Parchman M.L., Lawrence V.A., Valenstein M., Miller A.L. Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Services Research 2009, 9:127.
10. Elixhauser A., Steiner C., Harris D.R., Coffey R.M. Comorbidity measures for use with administrative data. Medical Care 1998, 36:8-27.
11. Evans-Lacko S.E., dosReis S., Kastelic E.A., Paula C.S., Steinwachs D.M. Evaluation of guideline-concordant care for bipolar disorder among privately insured youth. The Primary Care Companion to the Journal of Clinical Psychiatry 2010, 13(3):e1-e8.
12. Fan V.S., Maciejewski M.L., Liu C.F., McDonell M.B., Fihn S.D. Comparison of risk adjustment measures based on self-report, administrative data, and pharmacy records to predict clinical outcomes. Health Services and Outcomes Research Methodology 2006, 6:21-36.
13. Harrell F.E. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001, Springer-Verlag, New York, NY.
14. Hogan C.H., Lunney J., Gabel J., Lynn J. Medicare beneficiaries' costs of care in the last year of life. Health Affairs 2001, 20(4):188-195.
15. Risk Adjustment for Measuring Health Outcomes 1997, Health Administration Press, Chicago, IL. second edition. L.I. Iezzoni (Ed.).
16. Johns Hopkins University Johns Hopkins ACG Case-Mix Adjustment System Available at:, Site accessed July 29, 2010. http://www.acg.jhsph.edu.
17. Kilbourne A.M., Morden N.E., Austin K., Ilgen M., McCarthy J.F., Dalack G., Blow F.C. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. General Hospital Psychiatry 2009, 31:555-563.
18. Lambert B.L., Cunningham F.E., Miller D.R., Dalack G.W., Hur K. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. American Journal of Epidemiology 2006, 164(7):672-681.
19. Lubitz J.D., Riley G.F. Trends in Medicare payments in the last year of life. The New England Journal of Medicine 1993, 328:1092-1096.
20. McCarthy J.F., Blow F.C. Older patients with serious mental illness: sensitivity to distance barriers for outpatient care. Medical Care 2004, 42(11):1073-1080.
21. Petersen L.A., Pietz K., Woodard L.D., Byrne M. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Medical Care 2005, 43:61-67.
22. Pietz K., Petersen L.A. Comparing self-reported health status and diagnosis-based risk adjustment to predict 1- and 2-5 year mortality. Health Services Research 2007, 42:629-643.
23. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J.C., Saunders L.D., Beck C.A., Feasby T.E., Ghali W.A. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 2005, 43:1130-1139.
24. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Archives of General Psychiatry 2007, 64:1123-1131.
25. Starfield B., Weiner J., Murla P. Ambulatory care groups: a categorization of diagnoses for research and management. Health Services Research 1991, 26:53-74.
26. Steyerberg E.W. Clinical Prediction Models 2009, Springer-Verlag, New York, NY.
27. Sundararajan V., Henderson T., Perry C., Muggivan A., Quan H., Ghali W.A. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of Clinical Epidemiology 2004, 57:1288-1294.
28. The Johns Hopkins University Bloomberg School of Public Health, Health Services Research & Development Center. The Johns Hopkins ACG® Case-Mix System Version 6.0 Release Notes. (Editor in Chief: Jonathan P. Weiner). The Johns Hopkins University, April, 2003.
29. Weiner J., Starfield B., Steinwachs D., Abramson J. Development and application of a population-oriented measure of ambulatory care case-mix. Medical Care 1991, 29:452-472.